Global Medical REIT Declares Quarterly Dividends

TL;DR

GMED declared $0.20/share common dividend and $0.1875/share preferred dividend, payable June 28.

AI Summary

Global Medical REIT Inc. announced on May 16, 2024, that its Board of Directors has declared a quarterly cash dividend of $0.20 per share for its Class A common stock, payable on June 28, 2024, to stockholders of record as of June 14, 2024. The company also announced a quarterly cash dividend of $0.1875 per share for its Series A preferred stock, payable on June 28, 2024, to stockholders of record as of June 14, 2024.

Why It Matters

This dividend declaration indicates the company's continued financial stability and commitment to returning value to its shareholders, which can be a positive signal for investors.

Risk Assessment

Risk Level: low — The filing is a routine dividend declaration, which is a standard corporate action with low inherent risk.

Key Numbers

• $0.20 — Common Stock Dividend (Per share amount declared for Class A common stock.)
• $0.1875 — Preferred Stock Dividend (Per share amount declared for Series A preferred stock.)

Key Players & Entities

• Global Medical REIT Inc. (company) — Registrant
• May 16, 2024 (date) — Report Date
• May 15, 2024 (date) — Earliest Event Reported
• $0.20 (dollar_amount) — Common Stock Dividend
• $0.1875 (dollar_amount) — Preferred Stock Dividend
• June 28, 2024 (date) — Dividend Payment Date
• June 14, 2024 (date) — Record Date

FAQ

Key Financial Figures

• $0.001 — h registered: Common Stock, par value $0.001 per share GMRE NYSE Series A Pref

Filing Documents

• tm2414756d1_8k.htm (8-K) — 42KB
• 0001104659-24-062602.txt ( ) — 259KB
• gmre-20240515.xsd (EX-101.SCH) — 3KB
• gmre-20240515_def.xml (EX-101.DEF) — 26KB
• gmre-20240515_lab.xml (EX-101.LAB) — 36KB
• gmre-20240515_pre.xml (EX-101.PRE) — 25KB
• tm2414756d1_8k_htm.xml (XML) — 5KB

02 Departure of Directors or Certain

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) As described below under Item 5.07, at the 2024 annual meeting of stockholders of Global Medical REIT Inc. (the "Company") held on May 15, 2024 (the "2024 Annual Meeting"), the Company's stockholders approved an amendment to the Company's 2016 Equity Incentive Plan (the "Plan") to increase the number of shares reserved for issuance thereunder by 1,500,000 shares, which was previously approved by the Company's Board of Directors. The Plan is described in detail under "Proposal 4 – Amendment to 2016 Equity Incentive Plan" in the Company's proxy statement filed with the U.S. Securities and Exchange Commission on April 1, 2024, and the foregoing description is qualified in its entirety by reference to the full text of the Plan, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.

07 Submission of Matters to a Vote of Security

Item 5.07 Submission of Matters to a Vote of Security Holders. At the 2024 Annual Meeting, the Company's stockholders: (i) elected the seven nominated directors to the Company's Board of Directors, each to serve until the Company's 2025 annual meeting of stockholders and until her or his successor is duly elected and qualifies, (ii) approved, on an advisory basis, the compensation of the Company's named executive officers, (iii) recommended, on an advisory basis, that future advisory votes on named executive officer compensation be conducted every year, (iv) approved an amendment to the Plan to increase the number of shares reserved for issuance thereunder by 1,500,000 shares, and (v) ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. The full results of the matters voted on at the 2024 Annual Meeting are set forth below: Proposal 1 — Election of Directors: Nominee for Director For Against Abstain Broker Non-Votes Jeffrey M. Busch 33,520,679 2,266,304 77,283 13,706,818 Matthew Cypher 34,365,340 1,417,356 81,570 13,706,818 Ronald Marston 34,271,830 1,506,912 85,523 13,706,819 Henry E. Cole 35,307,015 471,399 85,852 13,706,818 Zhang Huiqi 35,307,700 463,912 92,658 13,706,814 Paula R. Crowley 35,321,456 459,003 83,810 13,706,815 Lori Wittman 34,362,196 1,408,313 93,758 13,706,817 Proposal 2 — Advisory Vote on Named Executive Officer Compensation: For Against Abstain Broker Non-Votes 33,764,849 1,467,056 632,359 13,706,820 Proposal 3 — Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 34,040,745 158,991 1,098,203 566,323 13,706,822 Proposal 4 — Amendment to the Company's 2016 Equity Incentive Plan to Increase the Number of Shares Reserved for Issuance The

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended through May 15, 2024) (incorporated by reference to Appendix A of Global Medical REIT Inc.'s Definitive Proxy Statement on Schedule 14A, filed on April 1, 2024) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Global Medical REIT Inc. By: /s/ Jamie A. Barber Jamie A. Barber Secretary and General Counsel Date: May 16, 2024

View Full Filing

View this 8-K filing on SEC EDGAR